With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback